Clinical Trial Update: Dose Comparison Study of Menactra® in US Children [Phase 2]

View source ↗

Summary

Phase 2 dose-comparison study of the Menactra meningococcal vaccine in US children; the study completed with results posted in December 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Infection
• Neisseria Meningitidis Infection

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Infection | Phase 2 | Status: COMPLETED | Results posted: 2010-12-23